Cardinal Health Inc (NYSE: CAH) has reported E.P.S. of $1.06 for its third fiscal quarter (ending March 31) versus $1.35 for the same period a year ago — a decline of -21%. Relative to the consensus estimate of $2.15, this was a shortfall of $-1.09. E.P.S. were $2.26 for the latest four quarters through March 31 versus $1.75 for the same period a year ago — an increase of 29%.
Recent Price Action
Cardinal Health Inc (NYSE: CAH) stock closed at $102.98 on 5/2/24 after a modest gain of 0.8%. Moreover, this advance was accompanied by unusually high trading volume at 158% of normal. The stock has declined -0.5% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, CAH is expected to be an important Value Eraser.
Cardinal Health is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment